Clinical assessment of endothelial dysfunction: combine and rule

被引:20
作者
Goligorsky, Michael S.
机构
[1] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA
关键词
cardiovascular complications; chronic kidney disease; endothelial cell dysfunction; inflammation; nitric oxide; oxidative stress;
D O I
10.1097/01.mnh.0000247497.62505.72
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To briefly survey the literature for the past 2-3 years on the subject of diagnostic and prognostic markers of endothelial cell dysfunction. Recent findings Established and emerging techniques to detect endothelial cell dysfunction are divided into two large families: (1) functional and structural markers of endothelial cell dysfunction, and (2) surrogate markers of endothelial cell dysfunction. The first category includes high-resolution Doppler studies of conduit arteries, laser Doppler flowmetry of cutaneous microvasculature, and measurements of arterial stiffness and intima: media thickness. The second category of tests provides brief descriptions of detection of oxidative stress, inflammation, coagulation abnormalities, circulating endothelial cells and microparticles. I also focus on integration of various techniques and some novel genomic, proteomic and metabolomic tests. Summary This snapshot of existing and emerging technologies diagnosing endothelial cell dysfunction is intended to provide the foundation for the future (a) development of personalized noninvasive screening of endothelial function, and (b) delineation of preclinical diagnostic biomarkers heralding cardiovascular complications.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 68 条
[21]   Endothelial microparticles as markers of endothelial dysfunction [J].
Horstman, LL ;
Jy, W ;
Jimenez, JJ ;
Ahn, YS .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :1118-1135
[22]   Lipoprotein-associated phospholipase A2 and cardiovascular risk -: State of the evidence and future directions [J].
Iribarren, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) :5-6
[23]   Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults [J].
Jenny, NS ;
Arnold, AM ;
Kuller, LH ;
Sharrett, AR ;
Fried, LP ;
Psaty, BM ;
Tracy, RP .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :107-113
[24]   Race-specific differences in endothelial function - Predisposition of African Americans to vascular diseases [J].
Kalinowski, L ;
Dobrucki, IT ;
Malinski, T .
CIRCULATION, 2004, 109 (21) :2511-2517
[25]  
Kirmizis D, 2006, MED SCI MONITOR, V12, pCR55
[26]   Kidney dysfunction, inflammation, and coronary events: A prospective study [J].
Knight, EL ;
Rimm, EB ;
Pai, JK ;
Rexrode, KM ;
Cannuscio, CC ;
Manson, JE ;
Stampfer, MJ ;
Curhan, GC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (07) :1897-1903
[27]   C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany [J].
Koenig, W ;
Löwel, H ;
Baumert, J ;
Meisinger, C .
CIRCULATION, 2004, 109 (11) :1349-1353
[28]   The clinical significance of endothelial dysfunction [J].
Landmesser, U ;
Drexler, H .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (06) :547-551
[29]   Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[30]   ACCELERATED ATHEROSCLEROSIS IN PROLONGED MAINTENANCE HEMODIALYSIS [J].
LINDNER, A ;
CHARRA, B ;
SHERRARD, DJ ;
SCRIBNER, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (13) :697-701